I. COMMENCED TRADING IN NOVEMBER | ||||||||
Company |
Date |
Date |
Shares/ |
Price | Shares |
Lead, Other |
Gross |
Post- |
|
| ||||||||
INITIAL OFFERINGS | ||||||||
Biotec |
9/30/05 |
11/4/05 |
3.922S |
NOK 24.50 |
21.49 |
DnB NOR Bank ASA |
NOK96 (US$14.4) |
NOK527 |
|
||||||||
CombinatoRx |
12/13/04 |
11/9/05 |
6.9S |
$7 |
23.22 |
SG Cowen & Co., Pacific Growth Equities (co-lead), Lazard Capital Markets, A.G. Edwards |
$48.3 |
$162.5 |
|
||||||||
ExonHit |
10/18/05 |
11/16/05 |
2.534S |
€2.89 |
21.80 |
Société Générale |
€7.3 |
€63.0 |
|
||||||||
Total: $71.3M | ||||||||
Number of IPOs in November: 3 | ||||||||
Average value of November IPOs: $23.77M | ||||||||
Number of IPOs in 2005: 31 | ||||||||
Total raised in IPOs in 2005: $1,408.99M | ||||||||
Average value of IPOs in 2005: $45.45M | ||||||||
|
||||||||
FOLLOW-ON OFFERINGS | ||||||||
Company |
Date |
Date |
Shares/ |
Price | Shares |
Lead, Other |
Gross |
Post- |
|
|
||||||||
Digene |
12/15/04 |
11/16/05 |
2S |
$28 |
22.14 |
JP Morgan Securities, Thomas Weisel Partners (co-lead), Goldman, Sachs & Co., SG Cowen & Co. |
$56 |
$619.9 |
|
||||||||
Durect Corp. |
10/27/05 |
11/2/05 |
8.22S |
$5 |
60.68 |
Morgan Stanley & Co., JP Morgan Securities (co-lead), CIBC World Markets Corp., WR Hambrecht + Co. |
$41.1 |
$303.4 |
|
||||||||
Myriad |
4/20/05 |
11/3/05 |
8.05S |
$18.50 |
39.00 |
JP Morgan Securities, Bear, Stearns & Co. (co-lead), UBS Securities (co-lead), Piper Jaffray & Co., First Albany Capital, JMP Securities |
$148.9 |
$721.5 |
|
||||||||
Onyx |
1/31/05 |
11/18/05 |
5S |
$25.25 |
40.39 |
Morgan Stanley & Co., Merrill Lynch & Co. (co-lead) |
$126.3 |
$1,019.8 |
|
||||||||
Pharmaxis |
8/31/05 |
11/8/05 |
19.5S |
$1.61 |
174.4 |
CIBC World Markets, JMP Securities |
$31.4 |
$280.8 |
|
||||||||
Point |
12/17/04 |
11/22/05 |
8.05S |
$3 |
31.54 |
Pacific Growth Equities, CIBC World Markets (co-lead) |
$24.15 |
$94.6 |
|
||||||||
Senomyx |
10/24/05 |
11/4/05 |
4.05S |
$14.60 |
29.66 |
Deutsche Bank Securities |
$59 |
$433.0 |
|
||||||||
OVERALLOTMENT OPTIONS | ||||||||
Dynavax |
8/29/05 |
11/10/05 |
0.72S |
$6.25 |
30.47 |
Bear, Stearns & Co., CIBC World Markets, Pacific Growth Equities |
$4.5 |
$190.4 |
|
||||||||
Total: $491.35M | ||||||||
Number of follow-on offerings in November: 7 | ||||||||
Average value of November follow-ons: $69.55M | ||||||||
Number of follow-on offerings in 2005: 54 | ||||||||
Total raised in follow-ons in 2005: $3,796.81M | ||||||||
Average value of follow-ons in 2005: $70.31M | ||||||||
|
||||||||
II. FILED AND PENDING | ||||||||
Company |
Date Filed | Shares/Units (M) | Price Range | Shares Out (M)@ | Lead, Other Underwriters | Value (M) |
INITIAL OFFERINGS | ||||||
Acorda |
10/5/05 |
N/A |
N/A |
N/A |
Banc of America, Lazard Capital Markets, Piper Jaffray & Co., SG Cowen & Co. |
$86.75 |
AlgoRx |
11/29/04 |
6.8S |
$7-$8 |
N/A |
Credit Suisse First Boston, Lazard Freres & Co., Citigroup (co-lead), Piper Jaffray & Co. |
$51 |
Altus |
10/17/05 |
N/A |
N/A |
N/A |
Merrill Lynch & Co., Morgan Stanley (co-lead), SG Cowen & Co. |
$115 |
BioNumerik |
6/9/04 |
5S |
$14-$16 |
N/A |
UBS Investment Bank, Needham & Co., Leerink Swann & Co., Punk, Ziegel & Co. |
$75 |
Corus |
8/27/04 |
N/A |
N/A |
N/A |
Merrill Lynch & Co., Pacific Growth Equities, SunTrust Robinson Humphrey, JMP Securities |
$100 |
Glycotex Inc. |
9/9/05 |
N/A |
N/A |
N/A |
Janney Montgomery Scott |
$39 |
Iomai Corp. |
10/3/05 |
N/A |
N/A |
N/A |
UBS Investment Bank, SG Cowen & Co., First Albany Capital, Susquehanna Financial |
$86.25 |
Molecular |
11/8/05 |
N/A |
N/A |
N/A |
Piper Jaffray & Co., SG Cowen & Co. (co-lead), Oppenheimer & Co., Roth Capital Partners |
$57.5 |
Prestwick |
4/22/05 |
N/A |
N/A |
N/A |
UBS Investment Bank, Deutsche Bank Securities, CIBC World Markets |
$74.75 |
SGX |
9/2/05 |
N/A |
N/A |
N/A |
CIBC World Markets, Piper Jaffray & Co. (co-lead), JMP Securities |
$80.5 |
Somaxon |
10/7/05 |
N/A |
N/A |
N/A |
Morgan Stanley & Co., JP Morgan Securities (co-lead), Piper Jaffray & Co., Thomas Weisel Partners |
$86.25 |
Valera |
3/14/05 |
N/A |
N/A |
N/A |
UBS Investment Bank, Banc of America (co-lead), First Albany Capital, Fortis Securities |
$74.75 |
Voyager |
9/9/05 |
5.9S |
$15-$19 |
N/A |
WR Hambrecht + Co. |
$100.3 |
FOLLOW-ON OFFERINGS | ||||||
Dendreon |
10/26/05 |
10S |
$5.90 |
N/A |
Banc of America Securities, JMP Securities, Lazard Capital Markets |
$59 |
Medivation |
10/6/05 |
8.7S |
$2.75 |
N/A |
Adams Harkness |
$23.9 |
ViroPharma |
10/19/01 |
7S |
$17 |
N/A |
Goldman, Sachs & Co., Piper Jaffray & Co. (co-lead), SG Cowen & Co., Lazard Capital Markets |
$119 |
WITHDRAWN AND POSTPONED | ||||||
Company |
Date |
Shares/ |
Price |
Shares |
Lead, Other Underwriters | Value |
Reliant |
5/20/05/ 11/17/05 |
N/A |
N/A |
N/A |
Goldman, Sachs & Co., Banc of America Securities, Deutsche Bank Securities, JP Morgan Securities, William Blair & Co., Lazard Capital Markets |
$300 |
Notes: | ||||||
# Unless otherwise indicated, shares are traded on the Nasdaq exchange; general shelf registration statements are not included until action is taken on the filing. | ||||||
* Stock symbols for companies seeking to complete IPOs are proposed. | ||||||
@ This column reflects the shares outstanding following the offering, when disclosed. | ||||||
N/A = Not available, applicable or reported. | ||||||
NYSE = New York Stock Exchange; OTC BB = Over-the-Counter Bulletin Board. | ||||||
1. Acorda filed to raise up to $86.75M in an IPO. It withdrew a previous IPO filing in January 2004. | ||||||
2. AlgoRx filed to raise up to $75M in an IPO. It reduced the price range in February. The value is based on the midpoint of that price range. It entered a merger agreement with the public company Corgentech Inc. on Sept. 26. | ||||||
3. Altus filed to raise up to $115M in an IPO. | ||||||
4. BioNumerik filed to raise up to $86.25M in an IPO. It later proposed selling 5M shares at $14 to $16 per share. The value is based on the midpoint of that price range. | ||||||
5. Corus filed to raise up to $100M in an IPO. | ||||||
6. Glycotex, a subsidiary of Novogen Ltd., filed to raise up to $39M in an IPO. | ||||||
7. Iomai filed to raise up to $86.25M in an IPO. | ||||||
8. Molecular Insight filed to raise up to $57.5M in an IPO. | ||||||
9. Prestwick filed to raise up to $74.75M in an IPO. | ||||||
10. SGX filed to raise up to $80.5M in an IPO. | ||||||
11. Somaxon filed to raise up to $86.25M in an IPO. | ||||||
12. Valera filed to raise up to $74.75M in an IPO. | ||||||
13. Voyager filed to raise up to $128.9M in an IPO. It proposed the price range on Oct. 14. The value is based on the midpoint of that range. | ||||||
14. Dendreon on Nov. 28 registered to sell 10M shares from an existing shelf registration. The value is based on the Nov. 28 closing price. | ||||||
15. Medivation registered to sell 8.7M shares in a follow-on offering. The value is based on the Oct. 14 closing price. | ||||||
16. ViroPharma on Nov. 28 registered to sell 7M shares from an existing shelf registration. The value is based on the Nov. 28 closing price. | ||||||
17. Reliant cited market conditions in withdrawing its proposed IPO. | ||||||